Clinical Trial Update: Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection in Healthy Chinese Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study assesses single and multiple intravenous doses of nalbuphine hydrochloride injection in healthy Chinese volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Nalbuphine hydrochloride injection (nalbuphine hydrochloride)

Snippet

Sponsor: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | Conditions: Pain | Phase 1 | Status: COMPLETED